Teleflex 2026 Outlook and Q1 Revenue Guidance Confirmation
Teleflex reported solid Q1 2026 revenue growth of 5.1% and confirmed its full-year guidance of 4.5% to 5.5%, despite near-term challenges such as supplier recalls.
Read postDetailed company information
Teleflex Incorporated is a global medical technology company dedicated to designing, developing, manufacturing, and distributing single-use medical devices. These products are crucial for diagnostic and therapeutic procedures, particularly within critical care and surgical environments worldwide. Its comprehensive product portfolio includes: Vascular Access Solutions: Featuring the "Arrow" brand, these include catheters, advanced catheter navigation and tip positioning systems, and intraosseous access systems. They are essential for administering intravenous therapies, monitoring blood pressure, and drawing blood samples, all achievable through a single access point. Interventional Cardiology & Radiology Products: This segment covers various coronary catheters, therapies for structural heart conditions, and devices for peripheral intervention and cardiac assist. Key users include interventional cardiologists, radiologists, and vascular surgeons. Specific offerings comprise Arrow, Guideline, and Trapliner catheters, the Manta Vascular Closure Device, and Arrow Oncontrol systems. Anesthesia and Surgical Products: The company provides anesthesia and pain management products, serving hospitals, emergency medical services, and military health organizations. Its surgical division offers metal and polymer ligation clips, fascial closure systems for laparoscopic procedures, percutaneous surgical systems, and a range of other surgical instruments. Interventional Urology & General Urology: Teleflex's interventional urology offerings prominently feature the UroLift System, an innovative treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH). Additionally, it supplies general urology products like catheters, urine collection devices, catheterization accessories, and tools for operative endourology, alongside providing bladder management services. Respiratory Care Products: This category includes oxygen and aerosol therapy devices, spirometry equipment, and ventilation management systems, applicable across diverse healthcare settings. Teleflex serves a broad customer base, encompassing hospitals, healthcare providers, medical device manufacturers, and the home care market. Established in 1943, the company maintains its headquarters in Wayne, Pennsylvania.
Last Updated: Sep 2026
Earnings Transcript for 2026 - Q2Released: Aug 06, 2026
Earnings Transcript for 2026 - Q1Released: May 07, 2026
Earnings Transcript for 2025 - Q4Released: Feb 26, 2026
Earnings Transcript for 2025 - Q3Released: Nov 06, 2025
Earnings Transcript for 2025 - Q2Released: Jul 31, 2025
Earnings Transcript for 2025 - Q1Released: May 01, 2025
Earnings Transcript for 2024 - Q4Released: Feb 27, 2025
Earnings Transcript for 2024 - Q3Released: Oct 31, 2024
Earnings Transcript for 2024 - Q2Released: Aug 01, 2024
Earnings Transcript for 2024 - Q1Released: May 02, 2024
Earnings Transcript for 2023 - Q4Released: Feb 22, 2024
Earnings Transcript for 2023 - Q3Released: Nov 05, 2023
Earnings Transcript for 2023 - Q2Released: Aug 03, 2023
Earnings Transcript for 2023 - Q1Released: May 06, 2023
Earnings Transcript for 2022 - Q4Released: Feb 23, 2023
Earnings Transcript for 2022 - Q3Released: Oct 27, 2022
Earnings Transcript for 2022 - Q2Released: Jul 28, 2022
Earnings Transcript for 2022 - Q1Released: Apr 28, 2022
Earnings Transcript for 2021 - Q4Released: Feb 24, 2022
Earnings Transcript for 2021 - Q3Released: Oct 28, 2021
Earnings Transcript for 2021 - Q2Released: Jul 29, 2021
Earnings Transcript for 2021 - Q1Released: May 02, 2021
Earnings Transcript for 2020 - Q4Released: Feb 28, 2021
Earnings Transcript for 2020 - Q3Released: Nov 01, 2020
ANGO AngioDynamics, Inc.
ICUI ICU Medical, Inc.
MMSI Merit Medical Systems, Inc.
HAE Haemonetics Corporation
NVST Envista Holdings Corp
ATR AptarGroup, Inc.
COO The Cooper Companies, Inc.
WST West Pharmaceutical Services, Inc.
RMD ResMed Inc.
BDX Becton, Dickinson and Company
FTV Fortive Corporation
UTMD Utah Medical Products, Inc.
Teleflex reported solid Q1 2026 revenue growth of 5.1% and confirmed its full-year guidance of 4.5% to 5.5%, despite near-term challenges such as supplier recalls.
Read postTeleflex’s 2025 Q4 earnings discussion highlights the expected regulatory milestones and timing to close two major divestitures in 2026. The company anticipates completing approvals and conditions within the year, deploying proceeds toward share repurchases and debt repayment.
Read post